10x Genomics (TXG) Market Capitalization (2019 - 2026)

10x Genomics has disclosed Market Capitalization across 8 years of filings, most recently posting $5.0 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 246.63% year-over-year to $5.0 billion; the TTM figure through Jun 2026 stood at $5.0 billion (up 246.63% YoY), while the FY2025 annual figure was $2.1 billion, up 18.59% from the prior year.
• Market Capitalization came in at $5.0 billion for Q2 2026 at 10x Genomics, up from $2.7 billion in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $8.6 billion in Q1 2022 to a low of $1.1 billion in Q1 2025.
• Average Market Capitalization over 5 years is $3.9 billion, with a median of $3.7 billion recorded in 2022.
• Year-over-year, Market Capitalization tumbled 79.93% in 2022 and soared 246.63% in 2026.
• Over 5 years, Market Capitalization stood at $4.2 billion in 2022, then soared by 58.77% to $6.7 billion in 2023, then tumbled by 73.65% to $1.8 billion in 2024, then increased by 18.59% to $2.1 billion in 2025, then surged by 139.84% to $5.0 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $5.0 billion in Q2 2026, $2.7 billion in Q1 2026, and $2.1 billion in Q4 2025.